benefits of tirzepatide over semaglutide & are transforming diabetes & obesity management. These GLP-1 receptor agonists offer from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from Tirzepatide vs Semaglutide 2026: 22%

The DRI modification makes the peptide backbone unrecognizable to endogenous aminopeptidases, carboxypeptidases, and endopeptidases, extending functional persistence from minutes to an estimated hours-to-days range

This places both compounds outside standard pharmaceutical distribution channels in Canada

Among the innovative options we offer is Ozempic ( semaglutide ), a medication that has shown substantial promise in supporting long-term weight loss

It was first isolated from human plasma in 1973 by Loren Pickart, and the tripeptide has since been identified in human saliva and urine

1 Follow-up visits took place at Week 20 for those who received the third Sculptra treatment and at Week 16 for those who did not

Lifestyle interventions remain the cornerstone of obesity management in older adults, with emphasis on resistance training for muscle strength and bone mineral density preservation